Mangoceuticals, Inc. (NASDAQ:MGRX) Short Interest Update

Mangoceuticals, Inc. (NASDAQ:MGRX) saw a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 124,200 shares, a decrease of 18.8% from the November 15th total of 152,900 shares. Based on an average daily volume of 365,800 shares, the days-to-cover ratio is currently 0.3 days. Currently, 9.1% of the company’s shares are short sold.

Institutional Trading of Mangoceuticals

An institutional investor recently bought a new position in Mangoceuticals stock. Ackerman Capital Advisors LLC bought a new position in Mangoceuticals, Inc. (NASDAQ:MGRX) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 873,356 shares of the company’s stock, valued at approximately $206,000. Ackerman Capital Advisors LLC owned about 3.52% of Mangoceuticals at the end of the most recent reporting period. 56.72% of the stock is owned by hedge funds and other institutional investors.

Mangoceuticals Stock Up 4.8 %

MGRX traded up $0.12 during trading on Friday, hitting $2.61. The company’s stock had a trading volume of 49,094 shares, compared to its average volume of 221,453. The firm has a market capitalization of $6.50 million, a P/E ratio of -0.45 and a beta of 2.09. Mangoceuticals has a twelve month low of $2.10 and a twelve month high of $16.80. The stock’s fifty day moving average price is $9.43 and its 200-day moving average price is $50.98.

About Mangoceuticals

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.